Table of Contents 1 Tumor-Specific Antigen Market Overview 1.1 Product Overview and Scope of Tumor-Specific Antigen 1.2 Classification of Tumor-Specific Antigen by Types 1.2.1 Global Tumor-Specific Antigen Revenue Comparison by Types (2019-2024) 1.2.2 Global Tumor-Specific Antigen Revenue Market Share by Types in 2018 1.2.3 Coding Region 1.2.4 Non-Coding Region 1.3 Global Tumor-Specific Antigen Market by Application 1.3.1 Global Tumor-Specific Antigen Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Drug Discovery and Development 1.3.3 Diagnostics 1.3.4 Clinical and Basic Research 1.3.5 Others 1.4 Global Tumor-Specific Antigen Market by Regions 1.4.1 Global Tumor-Specific Antigen Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Tumor-Specific Antigen Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Tumor-Specific Antigen Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tumor-Specific Antigen Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Tumor-Specific Antigen Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tumor-Specific Antigen Status and Prospect (2014-2024) 1.5 Global Market Size of Tumor-Specific Antigen (2014-2024) 2 Company Profiles 2.1 Agilent Technologies 2.1.1 Business Overview 2.1.2 Tumor-Specific Antigen Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Agilent Technologies Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 2.2 Roche 2.2.1 Business Overview 2.2.2 Tumor-Specific Antigen Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Roche Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 2.3 Lee Biosolutions 2.3.1 Business Overview 2.3.2 Tumor-Specific Antigen Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Lee Biosolutions Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 2.4 Creative Diagnostics 2.4.1 Business Overview 2.4.2 Tumor-Specific Antigen Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Creative Diagnostics Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 2.5 Caris Life Sciences 2.5.1 Business Overview 2.5.2 Tumor-Specific Antigen Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Caris Life Sciences Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 2.6 Go Therapeutics 2.6.1 Business Overview 2.6.2 Tumor-Specific Antigen Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Go Therapeutics Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 2.7 Merck Group 2.7.1 Business Overview 2.7.2 Tumor-Specific Antigen Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Merck Group Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 2.8 Biomrieux 2.8.1 Business Overview 2.8.2 Tumor-Specific Antigen Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Biomrieux Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 2.9 Bio-Rad 2.9.1 Business Overview 2.9.2 Tumor-Specific Antigen Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Bio-Rad Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 2.10 Abcam 2.10.1 Business Overview 2.10.2 Tumor-Specific Antigen Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Abcam Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 2.11 PerkinElmer 2.11.1 Business Overview 2.11.2 Tumor-Specific Antigen Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 PerkinElmer Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 2.12 OriGene Technologies 2.12.1 Business Overview 2.12.2 Tumor-Specific Antigen Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 OriGene Technologies Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) 3 Global Tumor-Specific Antigen Market Competition, by Players 3.1 Global Tumor-Specific Antigen Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Tumor-Specific Antigen Players Market Share 3.2.2 Top 10 Tumor-Specific Antigen Players Market Share 3.3 Market Competition Trend 4 Global Tumor-Specific Antigen Market Size by Regions 4.1 Global Tumor-Specific Antigen Revenue and Market Share by Regions 4.2 North America Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 4.3 Europe Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 4.5 South America Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 5 North America Tumor-Specific Antigen Revenue by Countries 5.1 North America Tumor-Specific Antigen Revenue by Countries (2014-2019) 5.2 USA Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 5.3 Canada Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 5.4 Mexico Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 6 Europe Tumor-Specific Antigen Revenue by Countries 6.1 Europe Tumor-Specific Antigen Revenue by Countries (2014-2019) 6.2 Germany Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 6.3 UK Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 6.4 France Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 6.5 Russia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 6.6 Italy Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Tumor-Specific Antigen Revenue by Countries 7.1 Asia-Pacific Tumor-Specific Antigen Revenue by Countries (2014-2019) 7.2 China Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 7.3 Japan Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 7.4 Korea Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 7.5 India Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 8 South America Tumor-Specific Antigen Revenue by Countries 8.1 South America Tumor-Specific Antigen Revenue by Countries (2014-2019) 8.2 Brazil Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 8.3 Argentina Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 8.4 Colombia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Tumor-Specific Antigen by Countries 9.1 Middle East and Africa Tumor-Specific Antigen Revenue by Countries (2014-2019) 9.2 Saudi Arabia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 9.3 UAE Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 9.4 Egypt Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 9.5 Nigeria Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 9.6 South Africa Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) 10 Global Tumor-Specific Antigen Market Segment by Type 10.1 Global Tumor-Specific Antigen Revenue and Market Share by Type (2014-2019) 10.2 Global Tumor-Specific Antigen Market Forecast by Type (2019-2024) 10.3 Coding Region Revenue Growth Rate (2014-2024) 10.4 Non-Coding Region Revenue Growth Rate (2014-2024) 11 Global Tumor-Specific Antigen Market Segment by Application 11.1 Global Tumor-Specific Antigen Revenue Market Share by Application (2014-2019) 11.2 Tumor-Specific Antigen Market Forecast by Application (2019-2024) 11.3 Drug Discovery and Development Revenue Growth (2014-2019) 11.4 Diagnostics Revenue Growth (2014-2019) 11.5 Clinical and Basic Research Revenue Growth (2014-2019) 11.6 Others Revenue Growth (2014-2019) 12 Global Tumor-Specific Antigen Market Size Forecast (2019-2024) 12.1 Global Tumor-Specific Antigen Market Size Forecast (2019-2024) 12.2 Global Tumor-Specific Antigen Market Forecast by Regions (2019-2024) 12.3 North America Tumor-Specific Antigen Revenue Market Forecast (2019-2024) 12.4 Europe Tumor-Specific Antigen Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Tumor-Specific Antigen Revenue Market Forecast (2019-2024) 12.6 South America Tumor-Specific Antigen Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Tumor-Specific Antigen Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Tumor-Specific Antigen Picture Table Product Specifications of Tumor-Specific Antigen Table Global Tumor-Specific Antigen and Revenue (Million USD) Market Split by Product Type Figure Global Tumor-Specific Antigen Revenue Market Share by Types in 2018 Figure Coding Region Picture Figure Non-Coding Region Picture Table Global Tumor-Specific Antigen Revenue (Million USD) by Application (2014-2024) Figure Tumor-Specific Antigen Revenue Market Share by Applications in 2018 Figure Drug Discovery and Development Picture Figure Diagnostics Picture Figure Clinical and Basic Research Picture Figure Others Picture Table Global Market Tumor-Specific Antigen Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024) Table Agilent Technologies Basic Information, Manufacturing Base and Competitors Table Agilent Technologies Tumor-Specific Antigen Type and Applications Table Agilent Technologies Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Tumor-Specific Antigen Type and Applications Table Roche Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table Lee Biosolutions Basic Information, Manufacturing Base and Competitors Table Lee Biosolutions Tumor-Specific Antigen Type and Applications Table Lee Biosolutions Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table Creative Diagnostics Basic Information, Manufacturing Base and Competitors Table Creative Diagnostics Tumor-Specific Antigen Type and Applications Table Creative Diagnostics Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table Caris Life Sciences Basic Information, Manufacturing Base and Competitors Table Caris Life Sciences Tumor-Specific Antigen Type and Applications Table Caris Life Sciences Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table Go Therapeutics Basic Information, Manufacturing Base and Competitors Table Go Therapeutics Tumor-Specific Antigen Type and Applications Table Go Therapeutics Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table Merck Group Basic Information, Manufacturing Base and Competitors Table Merck Group Tumor-Specific Antigen Type and Applications Table Merck Group Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table Biomrieux Basic Information, Manufacturing Base and Competitors Table Biomrieux Tumor-Specific Antigen Type and Applications Table Biomrieux Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table Bio-Rad Basic Information, Manufacturing Base and Competitors Table Bio-Rad Tumor-Specific Antigen Type and Applications Table Bio-Rad Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table Abcam Basic Information, Manufacturing Base and Competitors Table Abcam Tumor-Specific Antigen Type and Applications Table Abcam Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table PerkinElmer Basic Information, Manufacturing Base and Competitors Table PerkinElmer Tumor-Specific Antigen Type and Applications Table PerkinElmer Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table OriGene Technologies Basic Information, Manufacturing Base and Competitors Table OriGene Technologies Tumor-Specific Antigen Type and Applications Table OriGene Technologies Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018) Table Global Tumor-Specific Antigen Revenue (Million USD) by Players (2014-2019) Table Global Tumor-Specific Antigen Revenue Share by Players (2014-2019) Figure Global Tumor-Specific Antigen Revenue Share by Players in 2017 Figure Global Tumor-Specific Antigen Revenue Share by Players in 2018 Figure Global Top 5 Players Tumor-Specific Antigen Revenue Market Share in 2018 Figure Global Top 10 Players Tumor-Specific Antigen Revenue Market Share in 2018 Figure Global Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Tumor-Specific Antigen Revenue (Million USD) by Regions (2014-2019) Table Global Tumor-Specific Antigen Revenue Market Share by Regions (2014-2019) Figure Global Tumor-Specific Antigen Revenue Market Share by Regions (2014-2019) Figure Global Tumor-Specific Antigen Revenue Market Share by Regions in 2018 Figure North America Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Europe Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure South America Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Table North America Tumor-Specific Antigen Revenue by Countries (2014-2019) Table North America Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019) Figure North America Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019) Figure North America Tumor-Specific Antigen Revenue Market Share by Countries in 2018 Figure USA Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Canada Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Mexico Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Table Europe Tumor-Specific Antigen Revenue (Million USD) by Countries (2014-2019) Figure Europe Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019) Figure Europe Tumor-Specific Antigen Revenue Market Share by Countries in 2018 Figure Germany Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure UK Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure France Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Russia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Italy Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Table Asia-Pacific Tumor-Specific Antigen Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Tumor-Specific Antigen Revenue Market Share by Countries in 2018 Figure China Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Japan Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Korea Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure India Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Southeast Asia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Table South America Tumor-Specific Antigen Revenue by Countries (2014-2019) Table South America Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019) Figure South America Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019) Figure South America Tumor-Specific Antigen Revenue Market Share by Countries in 2018 Figure Brazil Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Argentina Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Colombia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Table Middle East and Africa Tumor-Specific Antigen Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Tumor-Specific Antigen Revenue Market Share by Countries in 2018 Figure Saudi Arabia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure UAE Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Egypt Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure Nigeria Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Figure South Africa Tumor-Specific Antigen Revenue and Growth Rate (2014-2019) Table Global Tumor-Specific Antigen Revenue (Million USD) by Type (2014-2019) Table Global Tumor-Specific Antigen Revenue Share by Type (2014-2019) Figure Global Tumor-Specific Antigen Revenue Share by Type (2014-2019) Figure Global Tumor-Specific Antigen Revenue Share by Type in 2018 Table Global Tumor-Specific Antigen Revenue Forecast by Type (2019-2024) Figure Global Tumor-Specific Antigen Market Share Forecast by Type (2019-2024) Figure Global Coding Region Revenue Growth Rate (2014-2019) Figure Global Non-Coding Region Revenue Growth Rate (2014-2019) Table Global Tumor-Specific Antigen Revenue by Application (2014-2019) Table Global Tumor-Specific Antigen Revenue Share by Application (2014-2019) Figure Global Tumor-Specific Antigen Revenue Share by Application (2014-2019) Figure Global Tumor-Specific Antigen Revenue Share by Application in 2018 Table Global Tumor-Specific Antigen Revenue Forecast by Application (2019-2024) Figure Global Tumor-Specific Antigen Market Share Forecast by Application (2019-2024) Figure Global Drug Discovery and Development Revenue Growth Rate (2014-2019) Figure Global Diagnostics Revenue Growth Rate (2014-2019) Figure Global Clinical and Basic Research Revenue Growth Rate (2014-2019) Figure Global Others Revenue Growth Rate (2014-2019) Figure Global Tumor-Specific Antigen Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Tumor-Specific Antigen Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Tumor-Specific Antigen Revenue Market Share Forecast by Regions (2019-2024) Figure North America Tumor-Specific Antigen Revenue Market Forecast (2019-2024) Figure Europe Tumor-Specific Antigen Revenue Market Forecast (2019-2024) Figure Asia-Pacific Tumor-Specific Antigen Revenue Market Forecast (2019-2024) Figure South America Tumor-Specific Antigen Revenue Market Forecast (2019-2024) Figure Middle East and Africa Tumor-Specific Antigen Revenue Market Forecast (2019-2024)

Agilent Technologies Roche Lee Biosolutions Creative Diagnostics Caris Life Sciences Go Therapeutics Merck Group Biomrieux Bio-Rad Abcam PerkinElmer OriGene Technologies